Previous study has reported NF-κB inhibitors DHMEQ and BAY 11-7082, by blocking the nuclear translocation of activated NF-κB were effective in inhibiting NPC HK1 cell growth, induced apoptosis and abrogated their invasiveness and anchorage independent growth104. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.